News

Data show 1 in 5 surgical patients who receive prescriptions for benzodiazepine go on to use them persistently.

Externalizing ADHD symptoms was linked to suicidality.

Vedolizumab treatment was associated with lower IMC recurrence rate after ICI resumption.

There are no guidelines on sickle cell patient referral to pulmonologists, associated outcomes, and best therapeutic interventions.

Jordana Hoppe, MD, highlights some key points about the genetic condition.

The reduction in heavy drinking in individuals between 18-25 years old is likely due to government restrictions on social gatherings.

The indication makes the Novo Nordisk product the first weekly injection GLP-1 agonist approved for managing overweight and obesity.

Data show HDP occurred in 7.4% of pregnancies in France during the study period.

A recommendation for all adults in the US to be screened for HCV has increased the need for treatment programs in urban areas.

Medtronic has halted sale of the HeartWare Ventricular Assist Device System after more than 100 complaints were filed, including 14 reports of mortality.

Seres expects to move forward with plans for SER-109 as a novel treatment for CDI.

A panel of retinal experts developed definitions for and classified the reasons behind patient nonadherence and nonpersistence.

Researchers compare 9 commonly used thermal care interventions for reduced core body temperatures.

Resolution of iron deficiency was associated with lower mortality; however, mortality risk was similar following resolution of anemia.

Greater symptoms of depression, anxiety, and ADHD were associated with less sleep.

More patients treated with risankizumab 360 mg achieved clinical remission than the induction-only control group.

There may be an association between atopic dermatitis severity and diagnosis of ocular disease, such as conjunctivitis.

The device is designed to assist in diagnosis to provide early intervention and appropriate care.

Data show 57.7% of patients achieved ≥20% improvement in joint symptoms and 53.4% achieved complete skin clearance at 1 year.

Stress induced by COVID-19 is driving opioid addiction risks. An expert weighs in on addressing one matter to resolve another.

Patients treated with ustekinumab had significantly more prior biologic use than patients treated with vedolizumab.

Positive detection rate for FH through next-generation sequencing was 27.0%, compared to 8.4% using 24-variant array based test.

The US is closing in on the goal of having 70% of adults vaccinated by July 4.

Secukinumab is the only fully human biologic that directly inhibits IL-17A.

All patients with severe disease had abnormal ECG readings.

New research sheds light on the relationship between sleep timing and the risk of developing major depressive disorder (MDD).

The oral combination therapy can also be used as acute treatment for manic or mixed episodes.

Data show low BMI, male gender, and older age in patients associated with higher overall mortality.